Management of Abnormal CMP in Alcoholic Cirrhosis

Initial Assessment and Management

Complete alcohol abstinence is the most important intervention to reduce the risk of complications and mortality in patients with alcoholic cirrhosis, as recommended by the European Association for the Study of the Liver 1, 2
Perform thorough evaluation of abnormal CMP values, focusing on liver synthetic function, hepatocellular injury, cholestasis, electrolyte imbalances, and renal function, according to the American Association for the Study of Liver Diseases 3, 4, 5, 6

Implement aggressive nutritional therapy rich in calories and proteins, as malnutrition affects up to 50% of patients with alcoholic liver disease, as recommended by the European Society for Clinical Nutrition and Metabolism 1, 6
Evaluate nutritional status using BMI and anthropometric measurements, and consider dietitian consultation in severe cases, according to the American Society for Parenteral and Enteral Nutrition 6, 1

Even moderate alcohol consumption can worsen portal hypertension and precipitate clinical decompensation, as reported by the American Association for the Study of Liver Diseases 3
Patients with alcoholic cirrhosis are particularly prone to bacterial infections, and should be treated with appropriate antibiotics, as recommended by the Infectious Diseases Society of America 1
Hepatic encephalopathy is associated with the highest mortality among complications of decompensated cirrhosis, and should be managed according to the European Association for the Study of the Liver guidelines 1
The annual incidence of hepatocellular carcinoma in alcoholic cirrhosis is approximately 2.6%, and decreases by 6-7% per year in abstinent patients, as reported by the American Association for the Study of Liver Diseases 3

Use caution with paracetamol in patients with alcoholic cirrhosis, particularly when malnourished, as recommended by the European Association for the Study of the Liver 6
Avoid disulfiram due to potential hepatotoxicity, and consider baclofen as a safe anti-craving drug in patients with advanced liver disease, according to the American Association for the Study of Liver Diseases 1

The MELD score is commonly used to establish prognosis and list patients for liver transplantation, as recommended by the United Network for Organ Sharing 1
Persistence of alcohol abuse is the most important factor increasing the risk of complications and death, as reported by the American Association for the Study of Liver Diseases 1, 3